drugset / Trial / NCT02375464

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

NCT02375464

Expanded access No longer available Northwell Health

Summary

Gallium-68 DOTATOC is a material used to find neuroendocrine tumors (NETs) using positron emission tomography (PET scan). The material has already been shown to be better than the currently available imaging agents. This study is designed to evaluate the clinical impact of PET CT scanning using this agent in the evaluation and management of patients with NETs.

Timeline

Start
2015-04
Primary completion
2018-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-DOTATOC Peptide